Do you want the task of keeping up-to-date to be enjoyable rather than a chore? Do you feel that you risk losing touch with advances occurring in medical specialties other than your own? If so, then keep reading.An Insider's Guide to the Medical Specialties is written to allow physicians of all grades to absorb kwledge with the minimum of effort, and a degree of pleasure. Generalists need to be skilled in the management of the early stages of a very diverse range of conditions. Never having heard of an investigation or hanging on to dated misconceptions about a patient's progsis can be frustrating at best, and dangerous at worst. The aim of this book is to strike a balance between refreshing old kwledge and updating the reader on significant advances that have occurred in a particular specialty. Over forty consultants and trainees have contributed to An Insider's Guide to the Medical Specialties. The content will be of interest to consultants and trainees in the medical specialties, general practitioners, and others. At times entertaining, irreverent and controversial, this is t a book to be left nestling in the pocket of a white coat or gathering dust on a shelf.
Dr Ian Reckless has been a Specialist Registrar in General Medicine since 2003. He has a particular interest in the quality of health services and the ways in which services are delivered. In addition to his clinical post, Ian has spent time as clinical adviser to the Healthcare Commission (the healthcare inspectorate in England) and working at the Department of Health. Dr John Reynolds was an undergraduate at Cambridge and a clinical student at Oxford, qualifying in 1981. After training posts in Bath, Newcastle, and Cambridge he returned to Oxford to undertake a DPhil in neuropharmacology. He was appointed Consultant Physician and Clinical Pharmacologist at the John Radcliffe Hospital in 1997 and is an honorary Senior Clinical Lecturer at the University of Oxford. For the last 4 years he has been Medical Director of Division A at the Oxford Radcliffe Hospitals NHS Trust and is currently Chairman of the Pharmaceutical Panel of the NHS Health Technology Assessment programme.